The pharmaceutical industry almost triples its investment in Spain
eleconomista.es Twenty years ago, few could have predicted the trajectory that drug research and development would follow in Spain. While the country grappled with the real estate bubble, the financial crisis, and ongoing political turmoil, investment by the pharmaceutical industry in this area nearly tripled, making the sector one of the most dynamic drivers of […]
35,000 new patients treated, 18,000 jobs created, and three million sick days avoided: the benefits of meeting EU targets for attracting clinical trials
These are the five-year figures estimated by a new study on the economic impact of industry-sponsored clinical research in the EU, published in Frontiers in Economics for the European Federation of Pharmaceutical Industries and Associations (EFPIA). Spain is the country that initiated the most studies in 2025, but together with Europe, it faces the challenge […]
Artificial intelligence enables more accurate stratification of breast cancer risk
An artificial intelligence model trained solely on mammography images demonstrates greater accuracy than breast density in estimating five-year breast cancer risk, paving the way for more personalized and earlier screening. consalud.es Breast cancer risk prediction could undergo a significant change thanks to artificial intelligence. A new study presented at the annual meeting of the Radiological […]
From potential to results: how pharmaceutical companies measure the impact of AI on their forecasts
elglobalfarma.com The global pharmaceutical industry is undergoing a quiet but profound transformation in the way it anticipates the future. A new report on forecasting and artificial intelligence (AI), produced by Evaluate Pharma, shows that compared to just a year ago, forecasting teams are operating in a much more demanding environment, where innovation is no longer […]
The ‘Guide to Excellence for Conducting Clinical Trials in Hospital Pharmacy’, recognized with the Diagnosis Award
The project, promoted by the Spanish Society of Hospital Pharmacy, the General Council of Pharmacists, and Farmaindustria, has won the award for Best Pharmaceutical Initiative at the Castilla y León Television Awards. José Andrés Santos (J&J), Eduardo Tejedor (SEFH), Amelia Martín Uranga (Farmaindustria), Ana Sangrador (Consejo General de COF) y Juan Manuel Corchado (Universidad de […]
Artificial intelligence accelerates drug development, but has yet to discover the miracle molecule
Although AI has not yet achieved major medical advances on its own, the industry already uses it to save time and costs and speed up trials. consalud.es Artificial intelligence (AI) has not yet solved the most complex challenge in drug development: discovering new molecules capable of transforming medicine. However, it is already significantly changing the […]
GEPAC and Farmaindustria sign an agreement to promote research, access to innovation, and the measurement of health outcomes in oncology
Both entities are committed to promoting activities that raise awareness of patient associations in Spain, with a special focus on organizations linked to oncology. Begoña Barragán, presidenta de GEPAC, y Fina Lladós, presidenta de Farmaindustria, en la firma del convenio entre ambas entidades. | Foto: Luis Camacho. Farmaindustria.es The Spanish Cancer Patient Group (GEPAC) and […]
The pharmaceutical industry values the ten commandments of good practice in the use of AI in drug development, drawn up by the EMA and the FDA.
Both regulatory agencies recognize the potential of this technology to transform biomedical innovation and hope to help lay the groundwork for joint work among stakeholders in this field. The pharmaceutical industry sees artificial intelligence as a great opportunity to transform healthcare, which requires clear regulatory frameworks that are aligned with the digital reality. Decalogo buenas […]
Spain once again leads clinical trials in Europe, but faces the challenge of competing in the global biomedical race
Our country authorized 962 studies last year, a hundred more than in 2023. Four out of every 10 research projects were dedicated to finding new cancer drugs. Spain is by far the European country that initiated the most studies in 2025 (849), followed by France (732), Germany (711), and Italy. (593). Geopolitical changes are transforming […]
Spain leads clinical research in the EU: 962 trials authorized and record administrative agility
The Spanish Registry of Clinical Studies points out that the country’s excellent hospital network and regulatory efficiency make it a strategic destination for the development of new drugs. consalud.es In 2025, Spain has managed to consolidate its position as the most active country in clinical research within the European Union, maintaining its leadership in both […]
ES
EN